Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. (XBIO) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 3 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jul 19, 2019 involved a transaction of 93,390 shares valued at $0.
XBIO Insider Activity Summary
Who Is Buying XBIO Stock?
No significant insider buying has been recorded for XBIO in the recent period.
Who Is Selling XBIO Stock?
No significant insider selling has been recorded for XBIO in the recent period.
Is Xenetic Biosciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for XBIO is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
XBIO Frequently Asked Questions
Understanding XBIO Insider Activity
Insider trading at Xenetic Biosciences, Inc. (XBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading XBIO stock, having executed 3 transactions in the past 90 days. The most active insider is Dmitry Genkin (Executive), who has made 2 transactions totaling $0.
Related Tools
Track Xenetic Biosciences, Inc. Insider Activity
Get notified when executives and directors at XBIO file new Form 4 transactions